Clearmind Medicine (FRA:CWY0) Days Payable: 0.00 (As of Apr. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:CWY0 Clearmind Medicine Inc FRA:CWY0
22 GF Score
Price €22.56
! 1 Warning Sign
View Full Analysis

What is Clearmind Medicine Days Payable?

Clearmind Medicine FRA:CWY0 22 Days Payable is 0.00 as of Apr. 2026. GuruFocus rates FRA:CWY0 with a GF Score™ of 22/100. The stock has 1 warning sign investors should review. Among 701 Biotechnology companies, Clearmind Medicine ranks worse than 142653.21% on this metric.

Clearmind Medicine's average Accounts Payable for the three months ended in Apr. 2026 was €0.69 Mil. Clearmind Medicine's Cost of Goods Sold for the three months ended in Apr. 2026 was €0.00 Mil.

The historical rank and industry rank for Clearmind Medicine's Days Payable or its related term are showing as below:

FRA:CWY0's Days Payable is not ranked *
in the Biotechnology industry.
Industry Median: 112.84
* Ranked among companies with meaningful Days Payable only.

Clearmind Medicine's Days Payable stayed the same from Apr. 2025 (0.00) to Apr. 2026 (0.00). stayed the same

Clearmind Medicine Days Payable Historical Data

* Premium members only.

The historical data trend for Clearmind Medicine's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Clearmind Medicine Days Payable Chart

Clearmind Medicine Annual Data
Trend Oct17 Oct18 Oct19 Oct20 Oct21 Oct22 Oct23 Oct24 Oct25
Days Payable
Get a 7-Day Free Trial Premium Member Only 0.00 0.00 0.00 0.00 0.00

Clearmind Medicine Quarterly Data
Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26 Apr26
Days Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

FRA:CWY0 vs ONCO, PPCB, REVB: Days Payable Comparison

For the Biotechnology subindustry, Clearmind Medicine's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Clearmind Medicine Days Payable vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Clearmind Medicine's Days Payable distribution charts can be found below:

* The bar in red indicates where Clearmind Medicine's Days Payable falls into.


FRA:CWY0
22GF Score
Clearmind Medicine Inc FRA:CWY0
Days Payable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Clearmind Medicine Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Clearmind Medicine's Days Payable for the fiscal year that ended in Oct. 2025 is calculated as

Days Payable (A: Oct. 2025 )
=Average Accounts Payable /Cost of Goods Sold*Days in Period
=( (Accounts Payable (A: Oct. 2024 ) + Accounts Payable (A: Oct. 2025 )) / count ) / Cost of Goods Sold (A: Oct. 2025 )*Days in Period
=( (0.483 + 0.586) / 2 ) / 0*365
=0.5345 / 0*365
=N/A

Clearmind Medicine's Days Payable for the quarter that ended in Apr. 2026 is calculated as:

Days Payable (Q: Apr. 2026 )
=Average Accounts Payable / Cost of Goods Sold*Days in Period
=( (Accounts Payable (Q: Jan. 2026 ) + Accounts Payable (Q: Apr. 2026 )) / count ) / Cost of Goods Sold (Q: Apr. 2026 )*Days in Period
=( (0.777 + 0.61) / 2 ) / 0*365 / 4
=0.6935 / 0*365 / 4
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Days Payable →
What does a Days Payable of 0.00 mean?
Clearmind Medicine (FRA:CWY0) has a Days Payable of 0.00 as of Apr. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Clearmind Medicine and its competitors. According to the industry distribution chart, Clearmind Medicine ranks #999999 out of 701 companies in the Biotechnology industry.
Is Clearmind Medicine's Days Payable too high?
Clearmind Medicine's current Days Payable is 0.00. Based on the distribution chart, Clearmind Medicine ranks #999999 out of 701 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Clearmind Medicine has a GF Score™ of 22/100, reflecting its overall financial health beyond just this single metric.
How does Clearmind Medicine's Days Payable compare to ONCO and PPCB?
According to the Biotechnology industry distribution chart, Clearmind Medicine ranks #999999 out of 701 companies for Days Payable. This places Clearmind Medicine in the lower half of its industry. The industry median Days Payable is 112.84. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Biotechnology company?
The median Days Payable among Biotechnology companies is 112.84, based on 701 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Clearmind Medicine and its competitors. For the Biotechnology industry, the median Days Payable is 112.84 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Clearmind Medicine's current Days Payable is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Clearmind Medicine stock overvalued right now?
Clearmind Medicine (FRA:CWY0) has a current Days Payable of 0.00. The current Days Payable is 0.00. Clearmind Medicine's overall GF Score™ is 22/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Clearmind Medicine (FRA:CWY0), the current Days Payable is 0.00 as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Clearmind Medicine Business Description

Other Exchanges CMND:USA
Address 101-1220 West 6th Avenue, Vancouver, BC, CAN, V6H1A5
Clearmind Medicine Inc is a clinical-stage pharmaceutical company engaged in Phase I/IIa clinical trials of novel psychedelic medicines. The Company focuses on developing treatments for mental health disorders, including alcohol use disorder (AUD), binge drinking, and eating disorders. Its activities are centered on the research and development of 5-methoxy-2-aminoindane (MEAI). It operates through a single research and development segment, which is conducted in Israel.
22GF Score

Get the complete analysis for FRA:CWY0

Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€22.56
Price